Matthew Harrison
Stock Analyst at Morgan Stanley
(3.47)
# 946
Out of 5,124 analysts
708
Total ratings
49.65%
Success rate
4.14%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| REGN Regeneron Pharmaceuticals | Maintains: Equal-Weight | $767 → $768 | $771.87 | -0.50% | 58 | Dec 12, 2025 | |
| MRNA Moderna | Maintains: Equal-Weight | $30 → $28 | $29.49 | -5.05% | 27 | Dec 12, 2025 | |
| LEGN Legend Biotech | Maintains: Overweight | $83 → $50 | $21.74 | +129.99% | 14 | Dec 12, 2025 | |
| GILD Gilead Sciences | Maintains: Overweight | $147 → $151 | $122.74 | +23.02% | 43 | Dec 12, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $149 → $156 | $175.99 | -11.36% | 56 | Dec 12, 2025 | |
| ARGX argenx SE | Maintains: Overweight | $1,070 → $1,110 | $840.95 | +31.99% | 27 | Dec 4, 2025 | |
| PHVS Pharvaris | Maintains: Overweight | $37 → $41 | $27.75 | +47.75% | 16 | Dec 4, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Maintains: Equal-Weight | $8 → $4 | $1.35 | +197.40% | 5 | Nov 12, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Overweight | $104 → $98 | $59.43 | +64.90% | 23 | Oct 28, 2025 | |
| DNLI Denali Therapeutics | Maintains: Overweight | $33 → $30 | $16.51 | +81.71% | 13 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $112 → $126 | $174.04 | -27.60% | 19 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $4 | $0.61 | +556.92% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $460 → $439 | $453.36 | -3.17% | 41 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $20 | $21.52 | -7.06% | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Positive | $215 | $191.39 | +12.34% | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6.2 → $6 | $3.57 | +68.07% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $5 | $0.71 | +602.74% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $178 | $142.50 | +24.91% | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $31.24 | +79.26% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $29.89 | +84.01% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $1.56 | +92.31% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $25.01 | -56.02% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $2.05 | +241.46% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $30.80 | +3.90% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $3.47 | +447.55% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $2.47 | -59.51% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $19.99 | -49.97% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $11.31 | -29.27% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $32.68 | +34.64% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $4.07 | +219.41% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $80 | $30.78 | +159.91% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $60 | $5.47 | +997.29% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $95.20 | +126.89% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $3.53 | +41.64% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $1.89 | +164.55% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $228.49 | -20.35% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $27.96 | -67.81% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $327.31 | -13.84% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $397.65 | -47.19% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $24.90 | +108.84% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $206.95 | -16.40% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $23.00 | +421.74% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $11.29 | +1,210.89% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $105.26 | -22.10% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $53.94 | +22.36% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $5.50 | +609.09% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $38.64 | +19.05% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $7.17 | +388.15% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $1,074.68 | -74.41% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $2.91 | +552.92% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $14.41 | +330.26% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $17.35 | -0.58% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $98.77 | -15.97% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $63.54 | -84.26% | 4 | Sep 10, 2018 |
Regeneron Pharmaceuticals
Dec 12, 2025
Maintains: Equal-Weight
Price Target: $767 → $768
Current: $771.87
Upside: -0.50%
Moderna
Dec 12, 2025
Maintains: Equal-Weight
Price Target: $30 → $28
Current: $29.49
Upside: -5.05%
Legend Biotech
Dec 12, 2025
Maintains: Overweight
Price Target: $83 → $50
Current: $21.74
Upside: +129.99%
Gilead Sciences
Dec 12, 2025
Maintains: Overweight
Price Target: $147 → $151
Current: $122.74
Upside: +23.02%
Biogen
Dec 12, 2025
Maintains: Equal-Weight
Price Target: $149 → $156
Current: $175.99
Upside: -11.36%
argenx SE
Dec 4, 2025
Maintains: Overweight
Price Target: $1,070 → $1,110
Current: $840.95
Upside: +31.99%
Pharvaris
Dec 4, 2025
Maintains: Overweight
Price Target: $37 → $41
Current: $27.75
Upside: +47.75%
Zentalis Pharmaceuticals
Nov 12, 2025
Maintains: Equal-Weight
Price Target: $8 → $4
Current: $1.35
Upside: +197.40%
BioMarin Pharmaceutical
Oct 28, 2025
Maintains: Overweight
Price Target: $104 → $98
Current: $59.43
Upside: +64.90%
Denali Therapeutics
Aug 18, 2025
Maintains: Overweight
Price Target: $33 → $30
Current: $16.51
Upside: +81.71%
Aug 13, 2025
Downgrades: Equal-Weight
Price Target: $112 → $126
Current: $174.04
Upside: -27.60%
Aug 12, 2025
Maintains: Overweight
Price Target: $6 → $4
Current: $0.61
Upside: +556.92%
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $460 → $439
Current: $453.36
Upside: -3.17%
Jul 29, 2025
Maintains: Equal-Weight
Price Target: $15 → $20
Current: $21.52
Upside: -7.06%
Jul 15, 2025
Initiates: Positive
Price Target: $215
Current: $191.39
Upside: +12.34%
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $3.57
Upside: +68.07%
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $0.71
Upside: +602.74%
Feb 21, 2025
Maintains: Buy
Price Target: $160 → $178
Current: $142.50
Upside: +24.91%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $31.24
Upside: +79.26%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $29.89
Upside: +84.01%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $1.56
Upside: +92.31%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $25.01
Upside: -56.02%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $2.05
Upside: +241.46%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $30.80
Upside: +3.90%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $3.47
Upside: +447.55%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $2.47
Upside: -59.51%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $19.99
Upside: -49.97%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $11.31
Upside: -29.27%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $32.68
Upside: +34.64%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $4.07
Upside: +219.41%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $140 → $80
Current: $30.78
Upside: +159.91%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $100 → $60
Current: $5.47
Upside: +997.29%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $95.20
Upside: +126.89%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $3.53
Upside: +41.64%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $1.89
Upside: +164.55%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $228.49
Upside: -20.35%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $27.96
Upside: -67.81%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $327.31
Upside: -13.84%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $397.65
Upside: -47.19%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $24.90
Upside: +108.84%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $206.95
Upside: -16.40%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $23.00
Upside: +421.74%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $11.29
Upside: +1,210.89%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $105.26
Upside: -22.10%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $53.94
Upside: +22.36%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $5.50
Upside: +609.09%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $38.64
Upside: +19.05%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $7.17
Upside: +388.15%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $1,074.68
Upside: -74.41%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $2.91
Upside: +552.92%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $14.41
Upside: +330.26%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $17.35
Upside: -0.58%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $98.77
Upside: -15.97%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $63.54
Upside: -84.26%